Video

Dr. Alexander Kretschmer explains how the ExoDx Prostate test works

Video Player is loading.
Current Time 0:00
Duration 2:04
Loaded: 7.92%
Stream Type LIVE
Remaining Time 2:04
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Dr. Alexander Kretschmer, MD, discusses the clinical interpretation and value of the ExoDx Prostate test (EPI test). The non-invasive, urine-based genomic test is a risk assessment tool that helps physicians and patients determine whether a prostate biopsy is necessary when PSA screening provides an ambiguous result.

    Kretschmer is an assistant professor of Urology at Ludwig-Maximilians-University Munich.

    © 2025 MJH Life Sciences

    All rights reserved.